---
source_pdf: "https://drive.google.com/file/d/1AMP7nPk1Dr4WQLENQEWh3OSRdJevA9o4hy2B9EomqWU/view"
drive_folder: "Portfolio/Mural Health"
type: portfolio
company: Mural Health
ingested: 2025-12-26
original_filename: "Mural"
---

> **Original:** [View Original PDF](https://drive.google.com/file/d/1AMP7nPk1Dr4WQLENQEWh3OSRdJevA9o4hy2B9EomqWU/view)

DIrect

Janssen, Meridian (site network), MedPACE, QueenNow, Total, Sage, MErck, AZ, Bausch, Eli,

Verbal award from Ionis

Indirect channel

Clinical ink

Shallow s&M effort

WCG - sounds like a diaster

Head of sales and exec - into it. No resources until the beginning of Q2. Towards end of this Q we’re coming back to him

Suvoda - Jageth is really difficult to get moving but no indicatoin that he isn’t interested

IQVIA - another fun discussion

Going through the legacy drug dev busienss with site payments

Seen Greenphire generating and see it as a pass-through and want to convert it. So visibly excited by it that it becomes apartment

Start with 2 or 3

50% penetration into new studies - $50M to us bookings

Proof Pilot

Moderna - introduced there

Interesting thing to be aware

Clincierge - coming to market

Travel agent for clinical trial patients

No sales force